Comerica Bank
AGRX

Comerica Bank’s Agile Therapeutics AGRX Stock Holding History

Comerica Bank’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$8 – 3860
2023
Q4 		$8 Hold
4
– – ﹤0.01% 3723
2023
Q3 		$10 Buy
+4
New +$10 ﹤0.01% 3786
2021
Q2 		– Sell
-6
Closed -$22K – 2369
2021
Q1 		$22K Hold
6
– – ﹤0.01% 2323
2020
Q4 		$35K Hold
6
– – ﹤0.01% 2312
2020
Q3 		$36K Hold
6
– – ﹤0.01% 2276
2020
Q2 		$30K Buy
+6
New +$31.2K ﹤0.01% 2255

Other funds holding AGRX

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Comerica Bank's AGRX Position: Q1 2024 in Review

Comerica Bank sold out of Agile Therapeutics (AGRX) in Q1 2024, closing a stake of 4 shares — an estimated $8 sold.

Comerica Bank first reported a position in AGRX in Q2 2020 and held it in 6 quarters. The position peaked at $36K in Q3 2020. 1 fund tracked by Wall St. Rank holds AGRX as of Q1 2024.

  • Comerica Bank reported no remaining Agile Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Comerica Bank sold 4 Agile Therapeutics shares in Q1 2024, an estimated $8.
  • Comerica Bank first reported a position in Agile Therapeutics in Q2 2020 and held it in 6 quarters.
  • Comerica Bank's Agile Therapeutics position peaked at $36K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Agile Therapeutics as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.